Leukocyte telomere length shortening
2 papers4 findings
Associations
4Rectal polyp
downin humans1HR 0.77
1 study
Rectal polyp
downin humans1HR 0.77
Leukocyte telomere length shortening lowers the risk of rectal polyp in humans (HR = 0.77, 95% CI: 0.63-0.92).
“The risk of rectal polyps (K621: HR = 0.77, 95% CI: 0.63-0.92) decreased per unit shortening of LTL.”
Humans11.8 years
Chinese medical journalDec 6, 2024
Non-alcoholic fatty liver disease
upin humans1HR 1.39
1 study
Non-alcoholic fatty liver disease
upin humans1HR 1.39
Leukocyte telomere length shortening raises the risk of non-alcoholic fatty liver disease in humans (HR = 1.39, 95% CI: 1.09-1.78).
“non-alcoholic fatty liver disease (NAFLD) (K760: HR = 1.39, 95% CI: 1.09-1.78)”
Humans11.8 years
Chinese medical journalDec 6, 2024
Liver cirrhosis
upin humans1HR 4.73
1 study
Liver cirrhosis
upin humans1HR 4.73
Leukocyte telomere length shortening raises the risk of liver cirrhosis in humans (HR = 4.73, 95% CI: 3.27-6.85).
“liver cirrhosis (K74: HR = 4.73, 95% CI: 3.27-6.85)”
Humans11.8 years
Chinese medical journalDec 6, 2024
Gastroesophageal reflux disease
upin humans1HR 1.3
1 study
Gastroesophageal reflux disease
upin humans1HR 1.3
Leukocyte telomere length shortening raises the risk of gastroesophageal reflux disease in humans (HR = 1.30, 95% CI: 1.19-1.42).
“LTL shortening is associated with an increased risk of several digestive diseases, including gastroesophageal reflux disease (K21: hazard ratio [HR] = 1.30, 95% confidence interval [95% CI]: 1.19-1.42)”
Humans11.8 years
Chinese medical journalDec 6, 2024